{"id":51620,"date":"2023-09-20T09:23:32","date_gmt":"2023-09-20T09:23:32","guid":{"rendered":"https:\/\/medsname.com\/cozartan\/"},"modified":"2026-05-01T10:49:11","modified_gmt":"2026-05-01T10:49:11","slug":"cozartan","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/cozartan\/","title":{"rendered":"Cozartan"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 R\u0103spuns rapid \u2014 Ce este Cozartan?<\/h3>\n<p style=\"margin:0;\"><strong>Cozartan<\/strong> este un <strong>losartan potasiu<\/strong> comprimat disponibil \u00een <strong>25, 50 \u0219i 100 mg<\/strong> doze. Este un <strong>blocator al receptorilor de angiotensin\u0103 II (ARB)<\/strong> utilizat pentru tratarea <strong>hipertensiune, nefropatie diabetic\u0103 \u0219i insuficien\u021b\u0103 cardiac\u0103<\/strong>, \u0219i pentru a <strong>reduce riscul de accident vascular cerebral<\/strong> la pacien\u021bii cu hipertrofie ventricular\u0103 st\u00e2ng\u0103. Doza obi\u0219nuit\u0103 pentru adul\u021bi este <strong>50 mg o dat\u0103 pe zi<\/strong>, ajust\u00e2ndu-se la 100 mg dac\u0103 este necesar. Echivalent clinic cu produsul Merck <strong>Cozaar<sup>\u00ae<\/sup><\/strong>.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n<p><strong>Cozartan<\/strong> este un generic Unichem <strong>losartan potasiu<\/strong> comprimat. Losartanul a fost primul blocant al receptorului de angiotensin\u0103 II (ARB) aprobat de FDA (1995) \u0219i r\u0103m\u00e2ne unul dintre cele mai prescrise medicamente pentru tensiune arterial\u0103 din lume. Cozartan con\u021bine acela\u0219i ingredient activ \u00een acelea\u0219i concentra\u021bii ca produsul de marc\u0103 Merck <strong>Cozaar<sup>\u00ae<\/sup><\/strong>.<\/p>\n<p>ARB-urile precum losartanul ofer\u0103 beneficiul de sc\u0103dere a tensiunii arteriale asem\u0103n\u0103tor inhibitorilor ACE (lisinopril, ramipril, perindopril) f\u0103r\u0103 caracteristica <strong>tuse uscat\u0103<\/strong> care determin\u0103 10\u201315% dintre pacien\u021bi s\u0103 \u00eentrerup\u0103 tratamentul cu inhibitori ACE. Din acest motiv, losartanul \u0219i alte ARB-uri sunt adesea alese ca tratament de prim\u0103 linie \u00een hipertensiunea arterial\u0103 esen\u021bial\u0103, \u00een special la pacien\u021bii care au experimentat tuse datorat\u0103 inhibitorilor ACE.<\/p>\n<h2 class=\"wp-block-heading\">Ce este Cozartan?<\/h2>\n<p>Cozartan este un antihipertensiv de prescrip\u021bie din clasa <strong>blocator al receptorilor de angiotensin\u0103 II (ARB)<\/strong> . Blocheaz\u0103 competitiv subtipul AT\u2081 al receptorului de angiotensin\u0103 II, reduc\u00e2nd efectele presoare, de re\u021binere a sodiului \u0219i vasoconstrictorii ale angiotensinei II.<\/p>\n<p>Cozartan este indicat pentru:<\/p>\n<ul>\n<li><strong>Hipertensiune arterial\u0103 esen\u021bial\u0103<\/strong> \u2014 tratament de prim\u0103 linie sau ca terapie adjunct\u0103<\/li>\n<li><strong>Nefropatia diabetic\u0103<\/strong> \u00een diabetul zaharat tip 2 \u2014 \u00eencetine\u0219te progresia bolii renale proteinurice<\/li>\n<li><strong>Hipertrofie ventricular\u0103 st\u00e2ng\u0103<\/strong> \u2014 reducerea riscului de accident vascular cerebral la pacien\u021bii cu HVST (studiul LIFE)<\/li>\n<li><strong>Insuficien\u021b\u0103 cardiac\u0103<\/strong> cu frac\u021bie de ejec\u021bie redus\u0103 \u2014 la pacien\u021bii intoleran\u021bi la inhibitori ACE<\/li>\n<li><strong>Boal\u0103 renal\u0103 cronic\u0103<\/strong> cu proteinurie \u2014 efect renoprotector<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Cum func\u021bioneaz\u0103 Cozartan?<\/h2>\n<p>Angiotensina II este hormonul efector al sistemului renin\u0103-angiotensin\u0103-aldosteron (RAAS). Cre\u0219te tensiunea arterial\u0103 prin trei mecanisme principale, toate blocate de losartan:<\/p>\n<ul>\n<li><strong>Vasoconstric\u021bie<\/strong> \u2014 antagonismul losartanului permite vasodilata\u021bie sistemic\u0103 \u0219i renal\u0103<\/li>\n<li><strong>Eliberare de aldosteron<\/strong> \u2014 blocarea reduce reten\u021bia de sodiu \u0219i ap\u0103<\/li>\n<li><strong>Stimulare simpatic\u0103 \u0219i remodelare cardiac\u0103<\/strong> \u2014 losartan reduce efectele hipertrofice \u0219i fibrotice pe termen lung ale angiotensinei II asupra inimii \u0219i rinichilor<\/li>\n<\/ul>\n<p>Losartanul \u00een sine este un blocator moderat al receptorilor. Efectul s\u0103u este \u00een mare m\u0103sur\u0103 mediat de metabolitul s\u0103u activ <strong>EXP3174<\/strong>, format de CYP2C9 \u00een ficat, care este de 10\u201340 de ori mai potent \u0219i are o timp de \u00eenjum\u0103t\u0103\u021bire de 6\u20139 ore. Acesta este motivul pentru care losartanul este de obicei administrat o dat\u0103 pe zi pentru controlul tensiunii arteriale.<\/p>\n<p><strong>Un beneficiu secundar distinctiv:<\/strong> losartanul este unic <strong>uricosuric<\/strong> printre BRA, reduc\u00e2nd acidul uric seric cu ~10\u201315%. Acest lucru \u00eel face un BRA preferat la pacien\u021bii hipertensivi cu gut\u0103 sau acid uric crescut.<\/p>\n<h2 class=\"wp-block-heading\">Doza \u0219i administrarea Cozartan<\/h2>\n<table>\n<thead>\n<tr>\n<th>Indica\u021bie<\/th>\n<th>Doz\u0103 ini\u021bial\u0103<\/th>\n<th>\u021aint\u0103 \/ Maxim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong>Hipertensiune arterial\u0103 (standard)<\/strong><\/td>\n<td>50 mg o dat\u0103 pe zi<\/td>\n<td>P\u00e2n\u0103 la 100 mg o dat\u0103 pe zi dup\u0103 3\u20136 s\u0103pt\u0103m\u00e2ni, dac\u0103 este necesar<\/td>\n<\/tr>\n<tr>\n<td><strong>Hipertensiune cu deple\u021bie de volum \/ la v\u00e2rstnici<\/strong><\/td>\n<td>25 mg o dat\u0103 pe zi<\/td>\n<td>Titra\u021bi progresiv pe m\u0103sur\u0103 ce este tolerat<\/td>\n<\/tr>\n<tr>\n<td><strong>Nefropatia diabetic\u0103<\/strong><\/td>\n<td>50 mg o dat\u0103 pe zi<\/td>\n<td>100 mg o dat\u0103 pe zi (doza \u021bint\u0103 conform studiului RENAAL)<\/td>\n<\/tr>\n<tr>\n<td><strong>Insuficien\u021b\u0103 cardiac\u0103 (intoleran\u021b\u0103 la inhibitori ACE)<\/strong><\/td>\n<td>12,5 mg o dat\u0103 pe zi<\/td>\n<td>Titra\u021bi p\u00e2n\u0103 la 50 mg (\u0219i p\u00e2n\u0103 la 150 mg \u00een studiul HEAAL)<\/td>\n<\/tr>\n<tr>\n<td><strong>HVST \/ reducerea riscului de accident vascular cerebral<\/strong><\/td>\n<td>50 mg o dat\u0103 pe zi<\/td>\n<td>100 mg o dat\u0103 pe zi (doza \u021bint\u0103 \u00een studiul LIFE)<\/td>\n<\/tr>\n<tr>\n<td><strong>Insuficien\u021b\u0103 hepatic\u0103<\/strong><\/td>\n<td>25 mg o dat\u0103 pe zi<\/td>\n<td>Losartanul \u0219i metabolitul s\u0103u sunt elimina\u021bi hepatic<\/td>\n<\/tr>\n<tr>\n<td><strong>Insuficien\u021b\u0103 renal\u0103 u\u0219oar\u0103\u2013moderat\u0103<\/strong><\/td>\n<td>Nu este necesar\u0103 ajustare de rutin\u0103<\/td>\n<td>Monitoriza\u021bi K\u207a \u0219i creatinina<\/td>\n<\/tr>\n<tr>\n<td><strong>Insuficien\u021b\u0103 renal\u0103 sever\u0103 \/ dializ\u0103<\/strong><\/td>\n<td>\u00cencepe\u021bi cu 25 mg; cu precau\u021bie<\/td>\n<td>Supraveghere specializat\u0103<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3 class=\"wp-block-heading\">Cum s\u0103 lua\u021bi corect Cozartan<\/h3>\n<ul>\n<li>\u00cenghi\u021bi\u021bi comprimatul \u00eentreg cu ap\u0103<\/li>\n<li>Poate fi luat cu sau f\u0103r\u0103 m\u00e2ncare (alimenta\u021bia reduce u\u0219or concentra\u021bia maxim\u0103 \u00een plasm\u0103 dar nu modific\u0103 efectul total)<\/li>\n<li>Lua\u021bi la <strong>moment \u00een fiecare zi<\/strong> pentru controlul constant al tensiunii arteriale<\/li>\n<li>Poate dura <strong>3\u20136 s\u0103pt\u0103m\u00e2ni<\/strong> p\u00e2n\u0103 la dezvoltarea efectului antihipertensiv complet; nu v\u0103 a\u0219tepta\u021bi la o schimbare imediat\u0103 a TA<\/li>\n<li><strong>Nu \u00eentrerupe\u021bi brusc<\/strong> \u00een insuficien\u021b\u0103 cardiac\u0103 sau dup\u0103 utilizare \u00eendelungat\u0103 \u2014 reduce\u021bi progresiv sub supraveghere medical\u0103<\/li>\n<li>Monitoriza\u021bi regulat TA; urm\u0103ri\u021bi obiectivele stabilite de medic (de obicei &lt;140\/90, sau &lt;130\/80 \u00een diabet \u0219i BCR)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Efecte secundare ale Cozartan<\/h2>\n<p>Losartanul este \u00een general bine tolerat \u2014 profilul de efecte secundare este mai bun dec\u00e2t al inhibitorilor ACE (f\u0103r\u0103 tuse caracteristic\u0103).<\/p>\n<table>\n<thead>\n<tr>\n<th>Severitate<\/th>\n<th>Efect Secundar<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong>Frecvente (\u22651 din 100)<\/strong><\/td>\n<td>Ame\u021beli (mai ales la prima doz\u0103), oboseal\u0103, cefalee, hipotensiune ortostatic\u0103<\/td>\n<\/tr>\n<tr>\n<td><strong>Pu\u021bin frecvente<\/strong><\/td>\n<td>Dureri lombare, congestie nazal\u0103, tulbur\u0103ri digestive u\u0219oare, hiperkaliemie tranzitorie, creatinin\u0103 crescut\u0103<\/td>\n<\/tr>\n<tr>\n<td><strong>Rare, dar grave<\/strong><\/td>\n<td>Angioedem (mult mai pu\u021bin frecvent dec\u00e2t la inhibitorii ACE, dar posibil), hiperkaliemie, leziune renal\u0103 acut\u0103 (\u00een special \u00een stenoz\u0103 bilateral\u0103 a arterei renale), hipotensiune sever\u0103, rabdomioliz\u0103<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Spre deosebire de inhibitorii ACE, ARB nu provoac\u0103 tusea persistent\u0103 caracteristic\u0103.<\/strong> Acesta este un motiv principal pentru a alege losartan \u00een loc de lisinopril sau ramipril la pacien\u021bii care au experimentat tuse.<\/p>\n<h2 class=\"wp-block-heading\">Avertismente \u0219i precau\u021bii<\/h2>\n<ul>\n<li><strong>Hipotensiune la prima doz\u0103.<\/strong> Pacien\u021bii cu volum depletat (sub diuretice, deshidrata\u021bi, diete s\u0103race \u00een sodiu) pot experimenta o sc\u0103dere marcat\u0103 a tensiunii arteriale. \u00cencepe\u021bi cu 25 mg \u0219i lua\u021bi prima doz\u0103 la culcare<\/li>\n<li><strong>Func\u021bia renal\u0103 \u0219i potasiu.<\/strong> Verifica\u021bi creatinina, eGFR \u0219i potasiul seric la 2\u20134 s\u0103pt\u0103m\u00e2ni dup\u0103 \u00eenceperea sau cre\u0219terea dozei. O u\u0219oar\u0103 cre\u0219tere a creatininei este de a\u0219teptat \u0219i NU este un motiv de \u00eentrerupere; o cre\u0219tere &gt;30% necesit\u0103 reevaluare<\/li>\n<li><strong>Stenoz\u0103 bilateral\u0103 a arterei renale.<\/strong> Evita\u021bi \u2014 poate precipita leziune renal\u0103 acut\u0103<\/li>\n<li><strong>Sarcina.<\/strong> <strong>Contraindica\u021bii<\/strong> \u2014 Blocatorii RAAS provoac\u0103 daune fetale \u00een trimestrul al doilea \u0219i al treilea (agenezie renal\u0103, oligohidramnios, hipoplazie cranian\u0103). \u00centrerupe\u021bi imediat dac\u0103 se descoper\u0103 sarcin\u0103<\/li>\n<li><strong>Al\u0103ptare.<\/strong> Nu este recomandat \u2014 se prefer\u0103 alternative<\/li>\n<li><strong>Angioedem.<\/strong> Rar, dar poten\u021bial letal \u2014 dac\u0103 apare umflarea c\u0103ilor respiratorii, \u00eentrerupe\u021bi imediat \u0219i c\u0103uta\u021bi ajutor medical de urgen\u021b\u0103<\/li>\n<li><strong>Litiu.<\/strong> Losartanul cre\u0219te nivelul de litiu \u2014 evita\u021bi sau monitoriza\u021bi \u00eendeaproape<\/li>\n<li><strong>AINS.<\/strong> Utilizarea regulat\u0103 a AINS poate anula efectul de sc\u0103dere a tensiunii arteriale \u0219i poate accelera deteriorarea renal\u0103<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Contraindica\u021bii \u2014 Cine NU ar trebui s\u0103 ia Cozartan<\/h2>\n<ul>\n<li>Sarcin\u0103 (toate trimestrele, dar mai ales al 2-lea \u0219i al 3-lea)<\/li>\n<li>Al\u0103ptare<\/li>\n<li>Hipersensibilitate la losartan sau la orice excipient<\/li>\n<li>Utilizarea concomitent\u0103 a aliskirenului la pacien\u021bii cu diabet<\/li>\n<li>Insuficien\u021b\u0103 hepatic\u0103 sever\u0103<\/li>\n<li>Stenoz\u0103 bilateral\u0103 a arterei renale<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<table>\n<thead>\n<tr>\n<th>Medicament \/ Clas\u0103<\/th>\n<th>Interac\u021biune<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong>Diuretice economisitoare de potasiu (spironolacton\u0103, amilorid\u0103) \/ suplimente de potasiu \/ \u00eenlocuitori ai s\u0103rii<\/strong><\/td>\n<td>Risc de hiperkaliemie \u2014 monitoriza\u021bi K\u207a<\/td>\n<\/tr>\n<tr>\n<td><strong>AINS (ibuprofen, naproxen, diclofenac)<\/strong><\/td>\n<td>Reduce efectul antihipertensiv; nefrotoxicitate aditiv\u0103 \u2014 evita\u021bi utilizarea regulat\u0103<\/td>\n<\/tr>\n<tr>\n<td><strong>Litiu<\/strong><\/td>\n<td>Reduce clearance-ul renal \u2014 cre\u0219te nivelurile de litiu; monitoriza\u021bi<\/td>\n<\/tr>\n<tr>\n<td><strong>Aliskiren (inhibitor direct al reninei)<\/strong><\/td>\n<td>Contraindica\u021bi la diabetici; evita\u021bi combina\u021bia la to\u021bi pacien\u021bii<\/td>\n<\/tr>\n<tr>\n<td><strong>Inhibitori ACE<\/strong><\/td>\n<td>Blocarea dubl\u0103 a RAAS nu este \u00een general recomandat\u0103 \u2014 risc crescut de AKI \u0219i hiperkaliemie<\/td>\n<\/tr>\n<tr>\n<td><strong>Inhibitori CYP2C9 (fluconazol, rifampicin\u0103)<\/strong><\/td>\n<td>Modific\u0103 conversia \u00een metabolitul activ EXP3174 \u2014 poate afecta eficacitatea<\/td>\n<\/tr>\n<tr>\n<td><strong>Alcool<\/strong><\/td>\n<td>Vasodilata\u021bie \u0219i hipotensiune aditiv\u0103 \u2014 consum moderat<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">Instruc\u021biuni de Depozitare<\/h2>\n<ul>\n<li>P\u0103stra\u021bi la temperaturi sub 30 \u00b0C, \u00eentr-un loc uscat, departe de lumina direct\u0103 a soarelui<\/li>\n<li>P\u0103stra\u021bi \u00een ambalajul original blister<\/li>\n<li>Se p\u0103streaz\u0103 \u00een afara accesului copiilor<\/li>\n<li>Nu utiliza\u021bi dup\u0103 data de expirare<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Alternative conexe pe MedsBase<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/losar\/\" rel=\"noopener\">Losar<\/a> \u2014 Unichem losartan, marc\u0103 alternativ\u0103<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/telma\/\" rel=\"noopener\">Telma<\/a> \u2014 telmisartan, un ARB \u00eenrudit cu timp de \u00eenjum\u0103t\u0103\u021bire mai lung (24 h)<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/high-blood-pressure-medication\/\" rel=\"noopener\">R\u0103sfoi\u021bi toate medicamentele pentru Tensiune \u2192<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/heart-blood-pressure\/\" rel=\"noopener\">Categorie Inim\u0103 \u0219i Tensiune<\/a><\/li>\n<\/ul>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">Pentru ce se folose\u0219te Cozartan?<\/h3>\n<p>Cozartan (losartan) este utilizat pentru tratarea <strong>hipertensiunii, nefropatiei diabetice, insuficien\u021bei cardiace \u0219i hipertrofiei ventriculare st\u00e2ngi<\/strong> (reducerea riscului de accident vascular cerebral). Este utilizat \u0219i \u00een boala renal\u0103 cronic\u0103 cu proteinurie datorit\u0103 efectului s\u0103u renoprotector.<\/p>\n<h3 class=\"wp-block-heading\">C\u00e2t de repede ac\u021bioneaz\u0103 Cozartan?<\/h3>\n<p>Un efect de sc\u0103dere a tensiunii arteriale \u00eencepe \u00een termen de <strong>6 ore<\/strong> de la prima doz\u0103. Efectul antihipertensiv complet se dezvolt\u0103 pe parcursul <strong>3\u20136 s\u0103pt\u0103m\u00e2ni<\/strong>. Majoritatea pacien\u021bilor ating tensiunea arterial\u0103 \u021bint\u0103 dup\u0103 titrarea dozei.<\/p>\n<h3 class=\"wp-block-heading\">Este losartanul mai bun dec\u00e2t un inhibitor al enzimei de conversie a angiotensinei?<\/h3>\n<p>Ambele sunt foarte eficiente. Principala diferen\u021b\u0103 practic\u0103 este <strong>tusea uscat\u0103 cauzat\u0103 de inhibitorii ACE<\/strong> (care afecteaz\u0103 ~10\u201315% dintre pacien\u021bi), pe care antagoni\u0219tii receptorilor de angiotensin\u0103 precum losartanul nu o provoac\u0103. \u00cen ceea ce prive\u0219te rezultatele cardiovasculare, cele dou\u0103 clase sunt \u00een mare parte similare.<\/p>\n<h3 class=\"wp-block-heading\">Pot lua Cozartan cu m\u00e2ncare?<\/h3>\n<p>Ambele variante sunt acceptabile. O mas\u0103 poate reduce u\u0219or concentra\u021bia maxim\u0103 \u00een plasm\u0103, dar nu afecteaz\u0103 efectul general de sc\u0103dere a tensiunii arteriale.<\/p>\n<h3 class=\"wp-block-heading\">Este losartan sigur \u00een timpul sarcinii?<\/h3>\n<p><strong>Nu<\/strong> \u2014 losartan este contraindiat \u00een sarcin\u0103. Poate provoca leziuni fetale grave, inclusiv malforma\u021bii ale rinichilor \u0219i hipoplazie cranian\u0103 \u00een trimestrele 2 \u0219i 3. Trece\u021bi la un antihipertensiv sigur \u00een sarcin\u0103 (labetalol, nifedipin\u0103, metildop\u0103) dac\u0103 sarcina este planificat\u0103 sau confirmat\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Cozartan scade acidul uric?<\/h3>\n<p>Da \u2014 losartan este singurul ARB cu activitate uricosuric\u0103 semnificativ\u0103, reduc\u00e2nd acidul uric seric cu aproximativ 10\u201315%. Prin urmare, este o alegere preferat\u0103 pentru pacien\u021bii hipertensivi care au \u0219i gut\u0103 sau niveluri ridicate de acid uric.<\/p>\n<h3 class=\"wp-block-heading\">Cozartan poate provoca tuse uscat\u0103?<\/h3>\n<p>Foarte pu\u021bin probabil. Tusea uscat\u0103 este un efect secundar al inhibitorilor ACE (legat de acumularea de bradikinin\u0103) \u0219i este rar \u00eent\u00e2lnit\u0103 la ARB-uri precum losartan.<\/p>\n<h3 class=\"wp-block-heading\">Pot s\u0103 opresc Cozartan odat\u0103 ce tensiunea mea arterial\u0103 este controlat\u0103?<\/h3>\n<p><strong>Nu<\/strong> \u2014 hipertensiunea este de obicei o afec\u021biune pe via\u021b\u0103. Oprirea medicamentului va determina revenirea tensiunii arteriale la nivelurile pre-tratament, pierz\u00e2nd protec\u021bia cardiovascular\u0103 pe termen lung.<\/p>\n<h3 class=\"wp-block-heading\">Pot lua Cozartan cu alte antihipertensive?<\/h3>\n<p>Da \u2014 terapia combinat\u0103 este norma. Combina\u021bii comune sunt cu blocante ale canalelor de calciu (amlodipin\u0103) sau diuretice tiazidice. Evita\u021bi combinarea cu inhibitori ACE sau aliskiren (blocare dubl\u0103 a RAAS).<\/p>\n<h3 class=\"wp-block-heading\">Ce ar trebui s\u0103 evit \u00een timp ce iau Cozartan?<\/h3>\n<p>NSAID-uri \u00een doze mari regulate, \u00eenlocuitori de sare care con\u021bin clorur\u0103 de potasiu, consumul excesiv de alcool \u0219i deshidratarea. Dac\u0103 v\u0103 \u00eemboln\u0103vi\u021bi cu v\u0103rs\u0103turi sau diaree, \u00eentrerupe\u021bi temporar doza \u0219i cere\u021bi sfatul medical \u2014 deshidratarea acut\u0103 + ARB poate provoca leziuni renale.<\/p>\n<p><!-- medsbase-faq-h3-converted --><\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>Afec\u021biuni cronice<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/lonax\/\">Lonax<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/sorbitrate\/\">Sorbitrate<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/lobet\/\">Lobet<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/ritocom\/\">Ritocom<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/olmin\/\">Olmin<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Scade tensiunea arterial\u0103 ridicat\u0103<br \/>\n\u2705 Reduce riscul de accident vascular cerebral<br \/>\n\u2705 Diminueaz\u0103 insuficien\u021ba cardiac\u0103<br \/>\n\u2705 Beneficii de protec\u021bie renal\u0103<br \/>\n\u2705 \u00cembun\u0103t\u0103\u021be\u0219te s\u0103n\u0103tatea cardiovascular\u0103<\/p>\n<p><span style=\"color: #000000;\">Cozartan con\u021bine Losartan<\/span><\/p>","protected":false},"featured_media":51621,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3260,3356],"product_tag":[5742,5746,5741,3383,5744,5745,5743,3384,4447],"class_list":{"0":"post-51620","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-heart-blood-pressure","9":"product_cat-high-blood-pressure-medication","10":"product_tag-arb","11":"product_tag-blood-pressure","12":"product_tag-cozaar-generic","13":"product_tag-cozartan","14":"product_tag-diabetic-nephropathy","15":"product_tag-heart-failure","16":"product_tag-hypertension","17":"product_tag-losartan","18":"product_tag-losartan-potassium","20":"first","21":"instock","22":"shipping-taxable","23":"purchasable","24":"product-type-variable","25":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/51620","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=51620"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/51621"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=51620"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=51620"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=51620"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=51620"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}